Purple Biotech Ltd (TLV:PPBT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
4.000
-0.100 (-2.44%)
May 29, 2025, 5:24 PM IDT

Purple Biotech Statistics

Total Valuation

Purple Biotech has a market cap or net worth of ILS 22.25 million. The enterprise value is -3.45 million.

Market Cap 22.25M
Enterprise Value -3.45M

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date May 15, 2025
Ex-Dividend Date n/a

Share Statistics

Purple Biotech has 542.78 million shares outstanding. The number of shares has increased by 37.04% in one year.

Current Share Class 542.78M
Shares Outstanding 542.78M
Shares Change (YoY) +37.04%
Shares Change (QoQ) -99.36%
Owned by Insiders (%) 0.30%
Owned by Institutions (%) 1.89%
Float 536.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 0.18
P/TBV Ratio 1.24
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.24
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.00.

Current Ratio 2.72
Quick Ratio 2.57
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -430.17

Financial Efficiency

Return on equity (ROE) is -12.40% and return on invested capital (ROIC) is -15.07%.

Return on Equity (ROE) -12.40%
Return on Assets (ROA) -12.83%
Return on Invested Capital (ROIC) -15.07%
Return on Capital Employed (ROCE) -23.58%
Revenue Per Employee n/a
Profits Per Employee -1.63M
Employee Count 9
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.05% in the last 52 weeks. The beta is -0.16, so Purple Biotech's price volatility has been lower than the market average.

Beta (5Y) -0.16
52-Week Price Change -84.05%
50-Day Moving Average 4.64
200-Day Moving Average 6.71
Relative Strength Index (RSI) 40.47
Average Volume (20 Days) 689,276

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit -230,857
Operating Income -28.83M
Pretax Income -14.72M
Net Income -14.64M
EBITDA -28.72M
EBIT -28.83M
Earnings Per Share (EPS) -0.04
Full Income Statement

Balance Sheet

The company has 26.39 million in cash and 510,120 in debt, giving a net cash position of 25.88 million or 0.05 per share.

Cash & Cash Equivalents 26.39M
Total Debt 510,120
Net Cash 25.88M
Net Cash Per Share 0.05
Equity (Book Value) 121.74M
Book Value Per Share 46.18
Working Capital 17.71M
Full Balance Sheet

Cash Flow

Operating Cash Flow -41.94M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Purple Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -37.04%
Shareholder Yield n/a
Earnings Yield -65.77%
FCF Yield n/a

Stock Splits

The last stock split was on January 6, 2019. It was a reverse split with a ratio of 0.05.

Last Split Date Jan 6, 2019
Split Type Reverse
Split Ratio 0.05

Scores

Altman Z-Score n/a
Piotroski F-Score n/a